Commerce Bank’s Opus Genetics IRD Stock Holding History

Commerce Bank’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-21	Closed	-$5K	–	846
2017 Q1	$5K	Buy	+21	New	+$2.72K	﹤0.01%	803

Other funds holding IRD

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HVIA

Hudson Valley Investment Advisors Goshen, New York $772M AUM 25.84% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Commerce Bank's IRD Position: Q2 2017 in Review

Commerce Bank sold out of Opus Genetics (IRD) in Q2 2017, closing a stake of 21 shares — an estimated $5K sold.

Commerce Bank first reported a position in IRD in Q1 2017 and held it in 1 quarter. The position peaked at $5K in Q1 2017. 23 funds tracked by Wall St. Rank hold IRD as of Q2 2017.

Commerce Bank reported no remaining Opus Genetics position as of Q2 2017 after selling out during the quarter.
Commerce Bank sold 21 Opus Genetics shares in Q2 2017, an estimated $5K.
Commerce Bank first reported a position in Opus Genetics in Q1 2017 and held it in 1 quarter.
Commerce Bank's Opus Genetics position peaked at $5K in Q1 2017.
23 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2017.

Based on Commerce Bank's 13F filing for Q2 2017, filed 8 Aug 2017.